Amicus Therapeutics’ first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy. Galafold ...

Amicus Therapeutics (FOLD) announced it will be acquired by BioMarin Pharmaceutical (BMRN) on Friday, December 19, 2025 for $4.8B paid in cash ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Marguerita is a Certified Financial Planner (CFP), Chartered Retirement ...

The court will hold oral arguments Tuesday in First Choice Women's Resource Centers v. Platkin, over whether a pro-life pregnancy center can sue New Jersey's Democratic attorney general in federal ...

Super Bowl-winning head coach Barry Switzer and 31 Olympians have signed an amicus brief in support of the legal defense to "save women's sports" ahead of two upcoming Supreme Court cases over trans ...

Amicus™ high collection efficiency yields multiple products per donor for the lowest-cost platelet production. It is designed to adapt to the requirements of different collection settings. Let our ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...